Join Biotech and Pharma industry experts as they converse on deal making trends. Learn how you can position your technology and/or company for success in the current environment.   Our seasoned panel will discuss the evolution of deal models in the life science industry from the 1980s to present day. Our panelist will touch upon issues relating to the size of the deals, valuations, early stage /late stage deals, and recent acquisition activity (Takeda/Millennium; AstraZeneca/MedImmune; Imclone/Lilly). A must attend for anyone interested in Biotech Pharma deal making.